Stock CXBS CORIX BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Corix Bioscience, Inc.

Equities

CXBS

US21887N1037

Market Closed - OTC Markets
Other stock markets
 20:43:00 08/01/2024 GMT 		5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Corix Bioscience, Inc. -.--% -99.00%
2018 Corix Bioscience, Inc. Terminates Employment of Michael Ogburn, Chief Executive Officer CI
2018 CanAfrica Holdings acquired Pharmaceutical Development Company Ltd from Corix Bioscience, Inc. for CAD 7 million. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CORIX BIOSCIENCE, INC. Stock Corix Bioscience, Inc.
 20 - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. CXBS Stock
  4. Charts Corix Bioscience, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW